Incorporating risk attitude into Markov-process decision models: Importance for individual decision making

被引:43
作者
Cher, DJ
Miyamoto, J
Lenert, LA
机构
[1] STANFORD UNIV,SCH MED,DEPT CLIN PHARMACOL,STANFORD,CA 94305
[2] PALO ALTO VA HLTH CARE SYST,DIV GEN INTERNAL MED,PALO ALTO,CA
[3] UNIV WASHINGTON,DEPT PSYCHOL,SEATTLE,WA 98195
关键词
risk attitude; Markov models; patient preferences; quality-adjusted life years;
D O I
10.1177/0272989X9701700311
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Most decision models published in the medical literature take a risk-neutral perspective. Under risk neutrality, the utility of a gamble is equivalent to its expected value and the marginal utility of living a given unit of time is the same regardless of when it occurs. Most patients, however, are not risk-neutral. Not only does risk aversion affect decision analyses when tradeoffs between short- and long-term survival are involved, it also affects the interpretation of time-tradeoff measures of health-state utility. The proportional time tradeoff under- or overestimates the disutility of an inferior health state, depending on whether the patient is risk-seeking or risk-averse (it is unbiased ii the patient is risk-neutral). The authors review how risk attitude with respect to gambles for survival duration can be incorporated into decision models using the framework of risk-adjusted quality-adjusted life years (RA-QALYs). They present a simple extension of this framework that allows RA-QALYs to be calculated for Markov-process decision models. Using a previously published Markov-process model of surgical vs expectant treatment for benign prostatic hypertrophy (BPH), they show how attitude towards risk affects the expected number of QALYs calculated by the model. In this model, under risk neutrality, surgery was the preferred option. Under mild risk aversion, expectant treatment was the preferred option. Risk attitude is an important aspect of preferences that should be incorporated into decision models where one treatment option has up-front risks of morbidity or mortality.
引用
收藏
页码:340 / 350
页数:11
相关论文
共 17 条
[1]   WHY SOME HEALTH POLICIES DONT MAKE SENSE AT THE BEDSIDE [J].
ASCH, DA ;
HERSHEY, JC .
ANNALS OF INTERNAL MEDICINE, 1995, 122 (11) :846-850
[2]   WATCHFUL WAITING VS IMMEDIATE TRANS-URETHRAL RESECTION FOR SYMPTOMATIC PROSTATISM - THE IMPORTANCE OF PATIENTS PREFERENCES [J].
BARRY, MJ ;
MULLEY, AG ;
FOWLER, FJ ;
WENNBERG, JW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 259 (20) :3010-3017
[3]  
KEENEY R. L., 1976, Decision with Multiple Objectives: Preferences and value tradeoffs
[4]   ADDITIVE CONJOINT-MEASUREMENT FOR MULTIATTRIBUTE UTILITY [J].
MAAS, A ;
WAKKER, P .
JOURNAL OF MATHEMATICAL PSYCHOLOGY, 1994, 38 (01) :86-101
[5]   FALLACY OF 5-YEAR SURVIVAL IN LUNG-CANCER [J].
MCNEIL, BJ ;
WEICHSELBAUM, R ;
PAUKER, SG .
NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (25) :1397-1401
[6]   SPEECH AND SURVIVAL - TRADEOFFS BETWEEN QUALITY AND QUANTITY OF LIFE IN LARYNGEAL-CANCER [J].
MCNEIL, BJ ;
WEICHSELBAUM, R ;
PAUKER, SG .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (17) :982-987
[7]  
MIYAMOTO J, 1997, IN PRESS MANAGEMENT
[8]  
Miyamoto J M, 1985, Med Decis Making, V5, P191, DOI 10.1177/0272989X8500500208
[9]   PARAMETRIC MODELS OF THE UTILITY OF SURVIVAL DURATION - TESTS OF AXIOMS IN A GENERIC UTILITY FRAMEWORK [J].
MIYAMOTO, JM ;
ERAKER, SA .
ORGANIZATIONAL BEHAVIOR AND HUMAN DECISION PROCESSES, 1989, 44 (02) :166-202
[10]   A MULTIPLICATIVE MODEL OF THE UTILITY OF SURVIVAL DURATION AND HEALTH QUALITY [J].
MIYAMOTO, JM ;
ERAKER, SA .
JOURNAL OF EXPERIMENTAL PSYCHOLOGY-GENERAL, 1988, 117 (01) :3-20